S-ICD associated with 92 percent reduction in lead-related complications typical in patients with ICDs
The randomized multicenter ATLAS trial of more than 500 persons has found that subcutaneous implantable cardioverter defibrillators (S-ICDs) reduce perioperative, lead-related complications without significantly compromising ...
Nov 8, 2022
0
2